Shanghai Shen Lian Biomedical Corporation (SHA:688098)

China flag China · Delayed Price · Currency is CNY
9.12
+0.06 (0.66%)
Mar 10, 2026, 2:04 PM CST
59.44%
Market Cap 3.72B
Revenue (ttm) 288.27M
Net Income (ttm) -19.09M
Shares Out 410.64M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,549,015
Average Volume 3,512,102
Open 9.16
Previous Close 9.06
Day's Range 9.09 - 9.23
52-Week Range 4.97 - 17.57
Beta 0.73
RSI 42.40
Earnings Date Apr 29, 2026

About SHA:688098

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 374
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688098
Full Company Profile

Financial Performance

In 2025, SHA:688098's revenue was 288.27 million, a decrease of -4.99% compared to the previous year's 303.41 million. Losses were -19.09 million, -57.33% less than in 2024.

Financial Statements

News

There is no news available yet.